Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Clinical Laboratory Techniques × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 3 Disease 2 Rectal Neoplasms 1 Pleural Effusion 1 Pleural Diseases 1 Pancreatitis, Chronic 1 Pancreatic carcinoma, familial 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Hereditary pancreatitis 1 Hematologic Diseases 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Bone Marrow Diseases 1

Interventions

pembrolizumab 152 Gemcitabine 137 Paclitaxel 128 Carboplatin 118 Bevacizumab 111 Surveys and Questionnaires 98 Docetaxel 96 Cisplatin 95 Cyclophosphamide 94 Exercise 89 Blood Specimen Collection 87 Nivolumab 84 Fluorouracil 75 Capecitabine 73 Dexamethasone 71 Radiotherapy 69 Irinotecan 62 Standard of Care 59 Pemetrexed 59 Oxaliplatin 57 Leucovorin 54 Drug Therapy 54 Cetuximab 48 Erlotinib Hydrochloride 46 atezolizumab 45 Sorafenib 44 Interviews as Topic 42 Doxorubicin 42 Ipilimumab 38 Magnetic Resonance Spectroscopy 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡